• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Bimaxillary full arch fixed dental implant supported treatment for a patient with renal failure and secondary hyperparathyroidism and osteodystrophy.

作者信息

Flanagan Dennis, Mancini Mark

机构信息

1  Private practice, Willimantic, Conn.

出版信息

J Oral Implantol. 2015 Apr;41(2):e36-43. doi: 10.1563/AAID-JOI-D-13-00188. Epub 2013 Dec 27.

DOI:10.1563/AAID-JOI-D-13-00188
PMID:24372491
Abstract

A long-term dialysis patient with end-stage renal disease (ESRD) also referred to as chronic kidney disease (CKD) due to IgA nephropathy complicated by severe secondary hyperparathyroidism and renal osteodystrophy was successfully treated with dental implant-supported fixed prostheses. Phosphate binders, vitamin D, calcium cinacalcet calcimimetic therapy, and dialysis 3 times weekly had been instituted with standard divalent ion serum assessments. Successful control of the patient's secondary hyperparathyroidism was achieved. Long and wide diameter implants were used with an anterior guidance occlusion scheme to reduce the per-square-millimeter off-axial implant force delivered to the bone. Patients with ESRD and renal osteodystrophy may be successfully surgically and prosthetically treated with long wide dental implants supporting fixed full arch splinted dental prostheses with an appropriate occlusal scheme.

摘要

相似文献

1
Bimaxillary full arch fixed dental implant supported treatment for a patient with renal failure and secondary hyperparathyroidism and osteodystrophy.
J Oral Implantol. 2015 Apr;41(2):e36-43. doi: 10.1563/AAID-JOI-D-13-00188. Epub 2013 Dec 27.
2
Cinacalcet: An oral calcimimetic agent for the management of hyperparathyroidism.西那卡塞:一种用于治疗甲状旁腺功能亢进的口服拟钙剂。
Clin Ther. 2005 Nov;27(11):1725-51. doi: 10.1016/j.clinthera.2005.11.015.
3
1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.1α(OH)D3 一α-羟基胆钙化醇——一种活性维生素 D 类似物。关于慢性透析的尿毒症患者继发性甲状旁腺功能亢进症预防和治疗的临床研究。
Dan Med Bull. 2008 Nov;55(4):186-210.
4
Cinacalcet treatment in dialysis patients with secondary hyperparathyroidism: effects and open issues.西那卡塞治疗透析患者继发性甲状旁腺功能亢进:疗效与未解决的问题
Ther Apher Dial. 2008 Oct;12 Suppl 1:S2-12. doi: 10.1111/j.1744-9987.2008.00624.x.
5
Tolerance and efficacy of a low dose of the calcimimetic agent cinacalcet in controlling moderate to severe secondary hyperparathyroidism in hemodialysis patients.低剂量拟钙剂西那卡塞在控制血液透析患者中重度继发性甲状旁腺功能亢进方面的耐受性和疗效
Saudi J Kidney Dis Transpl. 2015 Nov;26(6):1135-41. doi: 10.4103/1319-2442.168583.
6
Cinacalcet HCl: a novel treatment for secondary hyperparathyroidism caused by chronic kidney disease.盐酸西那卡塞:一种治疗慢性肾脏病所致继发性甲状旁腺功能亢进的新疗法。
J Ren Nutr. 2006 Jul;16(3):253-8. doi: 10.1053/j.jrn.2006.04.010.
7
The cost-utility of cinacalcet in addition to standard care compared to standard care alone for secondary hyperparathyroidism in end-stage renal disease: a UK perspective.从英国视角看,与单独标准治疗相比,西那卡塞联合标准治疗用于终末期肾病继发性甲状旁腺功能亢进的成本效益。
Nephrol Dial Transplant. 2007 May;22(5):1428-36. doi: 10.1093/ndt/gfl774. Epub 2007 Feb 17.
8
Long-term treatment of secondary hyperparathyroidism with the calcimimetic cinacalcet HCl.使用拟钙剂盐酸西那卡塞对继发性甲状旁腺功能亢进进行长期治疗。
Nephrol Dial Transplant. 2005 Oct;20(10):2186-93. doi: 10.1093/ndt/gfh966. Epub 2005 Jul 19.
9
Effect of Etelcalcetide vs Cinacalcet on Serum Parathyroid Hormone in Patients Receiving Hemodialysis With Secondary Hyperparathyroidism: A Randomized Clinical Trial.依特立钙对比西那卡塞对继发性甲状旁腺功能亢进行血液透析患者甲状旁腺激素的影响:一项随机临床试验。
JAMA. 2017 Jan 10;317(2):156-164. doi: 10.1001/jama.2016.19468.
10
[German observational trial on secondary hyperparathyroidism therapy with cinacalcet (EARLY)].[德国西那卡塞治疗继发性甲状旁腺功能亢进的观察性试验(EARLY)]
Dtsch Med Wochenschr. 2011 Jan;136(4):123-8. doi: 10.1055/s-0030-1247876. Epub 2010 Dec 21.

引用本文的文献

1
Evaluation of mandibular bone abnormalities in patients with chronic kidney disease using cone beam computed tomography: A retrospective study.使用锥形束计算机断层扫描评估慢性肾病患者的下颌骨异常:一项回顾性研究。
Acta Odontol Scand. 2025 Sep 3;84:517-526. doi: 10.2340/aos.v84.44619.
2
Resonance frequency analysis of dental implants in patients with vitamin D deficiency.维生素D缺乏患者牙种植体的共振频率分析
Clin Oral Investig. 2024 Dec 4;28(12):682. doi: 10.1007/s00784-024-06085-4.
3
Can Vitamin D Levels Influence Bone Metabolism and Osseointegration of Dental Implants? An Umbrella Review.
维生素D水平会影响骨代谢和牙种植体的骨结合吗?一项综述。
Healthcare (Basel). 2024 Sep 17;12(18):1867. doi: 10.3390/healthcare12181867.
4
Impact of Vitamin D on Osseointegration in Dental Implants: A Systematic Review of Human Studies.维生素 D 对牙种植体骨整合的影响:一项对人类研究的系统评价。
Nutrients. 2024 Jan 9;16(2):209. doi: 10.3390/nu16020209.
5
Implant Survival in Patients with Chronic Kidney Disease: A Case Report and Systematic Review of the Literature.慢性肾脏病患者的种植体存活情况:病例报告及文献系统回顾。
Int J Environ Res Public Health. 2023 Jan 29;20(3):2401. doi: 10.3390/ijerph20032401.
6
Does vitamin D have an effect on osseointegration of dental implants? A systematic review.维生素 D 对牙种植体的骨整合有影响吗?系统评价。
Int J Implant Dent. 2022 Apr 11;8(1):16. doi: 10.1186/s40729-022-00414-6.